Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancer.

Oing, Christoph; Bokemeyer, Carsten

Oing, Christoph; Bokemeyer, Carsten.

Affiliation

Oing C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Curr Opin Urol ; 28(5): 479-484, 2018 09.

Article in En | MEDLINE | ID: mdl-29957683

Subject(s)

Antineoplastic Agents, Immunological/therapeutic use; Drug Resistance, Neoplasm; Neoplasms, Germ Cell and Embryonal/drug therapy; Testicular Neoplasms/drug therapy; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; B7-H1 Antigen/metabolism; Cisplatin/therapeutic use; Humans; Lymphocytes, Tumor-Infiltrating/metabolism; Male; Neoplasms, Germ Cell and Embryonal/metabolism; Nivolumab/therapeutic use; Programmed Cell Death 1 Receptor/metabolism; Testicular Neoplasms/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Neoplasms, Germ Cell and Embryonal / Drug Resistance, Neoplasm / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: Curr Opin Urol Journal subject: UROLOGIA Year: 2018 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google